Clinical Trials Directory

Trials / Completed

CompletedNCT01635881

Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm PTCA Dilatation Catheter

EMERGE: Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilatation Catheter

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Boston Scientific Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To evaluate the acute safety and device procedural success of the Emerge 1.20 mm PTCA dilatation catheter when used as a pre-dilatation device in the stenotic portion of coronary arteries or bypass grafts.

Conditions

Interventions

TypeNameDescription
DEVICEEmerge™ 1.20 mm PTCA Dilatation CatheterThe Emerge 1.20 mm device is the next-generation Boston Scientific PTCA dilatation catheter. It is a sterile, single-use, intravascular medical device used to improve lumen diameter. The catheter consists of a shaft with a balloon near the distal tip. The balloon is designed to provide an inflatable segment of known diameter and length at recommended pressures.

Timeline

Start date
2012-07-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2012-07-10
Last updated
2013-11-06
Results posted
2013-11-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01635881. Inclusion in this directory is not an endorsement.